Delivery Order SPE2DB22D3004-SPE2DB24FND53
Award Date 10/11/23
Potential Completion Date 10/12/23
Potential Value $841
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $826.12 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561419790 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance is July 6-7, 2023. Under this delivery order, Amerisourcebergen will provide Repatha, a PCSK9 inhibitor medication used to reduce cholesterol, to the Defense Logistics Agency in support of its...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,652.31 to supply REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML pharmaceutical products. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by November 14, 2023. No set-aside designation was applied to this order placed against indefinite delivery contracts held by Amerisourcebergen with the DLA Troop Support Medical to...
- The Defense Logistics Agency Troop Support Medical awarded a $2,668.84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561625500 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 27-28, 2023. This delivery order was issued against an existing DLA medical supply vehicle to provide the specified pharmaceutical product. Amerisourcebergen will serve as the prime contractor to supply Repatha, a...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $2,934.99 to supply REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML pharmaceutical products. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by December 11, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract to provide pharmaceuticals and medical supplies in support of...
- The Defense Logistics Agency Troop Support Medical awarded a $62,858.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for REPATHA 140 MG/ML SURECLICKML. The place of performance is Conshohocken, Pennsylvania. The contract period runs from August 4-7, 2023. Under this contract, Amerisourcebergen will provide Repatha, a PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol levels in adult patients. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded a $3,872 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562267355 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of the specified pharmaceutical product and has a period of performance from September 21-22, 2023. As a major provider of medical supplies and services to the Department of Defense, this order supports the...
- The Defense Logistics Agency Troop Support Medical awarded a $319,370 delivery order to Amerisourcebergen Drug Corporation for 4561411771 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML. The place of performance is Conshohocken, Pennsylvania. The firm fixed price order has a period of performance from July 5-6, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the Department of Defense, including procuring pharmaceuticals and...
- Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, has been awarded a $508 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 140 mg/ml Repatha syringes. The order is to be performed in Conshohocken, Pennsylvania over a period of 3 days from September 29th through October 2nd, 2023. Repatha is a PCSK9 inhibitor medication used to reduce low-density lipoprotein cholesterol. This delivery order was issued under DLA's Prime...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,916 firm fixed price delivery order by the Defense Logistics Agency for the provision of 4561771314 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML injectable medications. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 10th to August 11th, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense,...
- The Defense Logistics Agency awarded a $319,370 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561584591 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML. The place of performance is Conshohocken, Pennsylvania. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified medication to fulfill agency requirements...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FND53Delivery Order
Amerisourcebergen Drug Corp has been awarded an $841 firm fixed price delivery order against an unidentified contract vehicle to supply 4562449863 REPATHA 420 MG/3.5ML PUSHTRONX 3.5ML to the Defense Logistics Agency. The order has a period of performance through October 12, 2023 for product delivery to a location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. The Defense Logistics Agency manages the global supply chain for the United States military and will utilize the purchased Repatha, a PCSK9 inhibitor medication, to support patient care within its healthcare programs.
Generated 1/10/24, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $841 | 10/11/23 |